Gush

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gush

Defining Gush: Identity and Classification

Gush is a pharmaceutical product containing the single active ingredient, Lactulose, which is chemically defined as a synthetic disaccharide. This medicine is categorized as an Osmotic Laxative, a pharmacological class defined by its specific mechanism of action. It is typically supplied as an oral solution or syrup, an aqueous liquid intended for consumption.

The structure of Lactulose is designed to resist breakdown in the upper gastrointestinal tract. This compound is non-absorbable in the small intestine, a feature ensuring the active ingredient is non-systemic and travels virtually unabsorbed to the colon, which is the site of its intended action. This mechanism is characterized by its action on the digestive system.

Composition, Non-Absorption, and Primary Purpose

The core composition of the medicine involves the Lactulose active ingredient prepared in an aqueous vehicle, as it is formulated for oral route administration. The primary purpose of this formulation is to promote regularity by increasing the fluid content of the stool.

This function occurs because the undigested Lactulose creates an osmotic gradient in the large intestine, drawing water into the bowel lumen. This influx of fluid softens the stool and increases its volume, which in turn facilitates movement within the bowel. This osmotic action works by increasing stool water content in the colon. This mechanism is utilized across various patient populations, including in pediatrics, where a soft, non-irritating process is preferred.

Regulatory References

  1. recognized globally for its mechanism of action

What side effects are possible with Gush?

Possible Side Effects and Safety Information

The official safety profile for Gush (Lactulose) defines potential side effects primarily in the Gastrointestinal Disorders system, which aligns with its non-systemic mechanism of action. Precise frequency data are not available in regulatory documents to classify effects as very common, common, or rare.

Reported adverse reactions include flatulence, intestinal cramps, nausea, and vomiting. These effects are often associated with initial dosing and are documented to be transient (short-lived). Diarrhea is also listed, particularly with excessive dosage.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions are specifically associated with excessive dosage of the medicine, which can lead to severe diarrhea. The documented complications include loss of fluids, hypokalemia (low potassium), and hypernatremia (high sodium), which represent disorders of the Metabolism and Nutrition system.

Safety limitations include a contraindication for patients who require a low galactose diet due to the presence of galactose and lactose in the product. The regulatory label also advises caution for use in individuals with diabetes.

Furthermore, the official label notes that safety and effectiveness have not been established for use in pediatric patients. Use during pregnancy is advised only if clearly needed, and caution is noted regarding use by nursing mothers.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile for Gush (Lactulose) based on the expected exaggeration of its osmotic action within the gastrointestinal tract. Overdosage most commonly results in clinical manifestations such as diarrhea and abdominal cramps or abdominal pain.

Documented Overdose Outcomes and Actions

The primary concern with overdosage relates to the risk of secondary systemic complications resulting from prolonged, excessive fluid loss. These complications include dehydration and a potentially severe electrolyte imbalance, such as hypokalemia (low potassium) and hypernatremia (high sodium).

  • Mandated Action: If an overdosage occurs, the primary action required by regulatory instruction is the immediate cessation of treatment or dose reduction.
  • Urgent Medical Help: Medical attention must be sought when the effects of overdosage, specifically severe diarrhea or vomiting, lead to suspected signs of fluid loss or electrolyte imbalance that require medical correction.
  • Antidote Status: The official prescribing information states that no specific antidote is known for Lactulose overdosage. Management is supportive, focusing on correcting fluid and electrolyte disturbances.

Patients prone to developing electrolyte disorders, such as those with hepatic or renal impairment, are noted to be at increased risk of these systemic complications following an overdose.

Therapeutic Uses of Gush

Quick Facts: Uses of Gush

Therapeutic Domain Primary Purpose
Digestive Health Management of constipation and promotion of regular bowel movements.
Symptom Relief Supports the reduction of symptoms associated with Irritable Bowel Syndrome (IBS), such as bloating.

Gush is an approved medication utilized for the management of chronic idiopathic constipation (CIC) in adults. It is intended to help resolve discomfort and support the return to a regular bowel routine. The therapeutic goals of Gush also encompass the management of certain symptoms associated with Irritable Bowel Syndrome (IBS), including the reduction of abdominal discomfort and bloating.

Treatment with this medication may facilitate the easy passage of stools, thereby offering relief from the physical strain related to constipation, fissures, or hemorrhoids. Additionally, the use of Gush may serve as supportive care by contributing to overall gut health. Information regarding the approved uses and safety considerations is available to ensure appropriate use.

This option may be prescribed to improve the overall quality of life for individuals dealing with long-term digestive challenges by promoting intestinal movement and stool softening. A healthcare professional determines if this treatment is appropriate for a patient’s specific health needs.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

This section outlines the official population eligibility and non-eligibility for Gush (Lactulose), based strictly on regulatory prescribing information.

Who Must Not Use Gush (Contraindications)

Gush is formally contraindicated and must not be used in individuals with the following conditions:

  • Galactosaemia (due to the presence of small amounts of galactose).
  • Gastrointestinal obstruction (except normal constipation), perforation, or risk of perforation.
  • Acute inflammatory bowel disease (e.g., Crohn's disease, Ulcerative Colitis).
  • Known Hypersensitivity to the active ingredient or excipients.

Age and Condition-Based Eligibility

Population Group Official Eligibility Status
Adults and Adolescents Approved for use.
Children and Infants Use must be exceptional and under medical supervision.
Pregnant Individuals Can be used if necessary (negligible systemic absorption).
Breastfeeding Individuals Can be used (negligible systemic exposure).
Diabetic Patients Use with caution due to the presence of small amounts of unabsorbed sugars.
Older Adults (Long-Term Use) Requires periodic control of serum electrolytes if used for more than six months.

What should I know about interactions with other medicines?

The official interaction profile for Gush (Lactulose) is structured around two key pharmacodynamic consequences of its non-systemic action in the colon.

Colonic Environment Alteration

The medicine reduces the pH within the colon. Co-administration with non-absorbable antacids may inhibit this pH change, potentially resulting in a lack of desired therapeutic effect. Conversely, the pH reduction can also inactivate drugs whose release is dependent on a specific colonic pH, such as certain 5-ASA compounds.

Timing-based rules exist for certain agents. The official labeling mandates a separation period for the oral compound Lanthanum Carbonate, which should not be administered within two hours of Gush.

Electrolyte Balance Risk

Prolonged or high-dose use carries a risk of secondary potassium loss. Therefore, caution is required when co-administering with other medications that promote potassium depletion, including thiazide diuretics, corticosteroids, and the antifungal agent Amphotericin B. This potential hypokalemia is clinically relevant as it may amplify the effects, and associated toxicity, of cardiac glycosides.

Population and Monitoring Notes

Official regulatory documents require the periodic measurement of serum electrolytes for elderly or debilitated patients receiving treatment for extended durations. Caution is also noted for use in patients with Diabetes Mellitus due to the presence of residual sugars (galactose and lactose).

Mechanism of Action

Targeting Key Signaling Receptors

Gush works by selectively engaging with defined receptor or enzyme systems that govern the activity of specific physiological pathways. This targeted binding is the initial step that allows Gush to modulate the signal, directly influencing the transmission of information within the body's regulatory systems.


Modulating Signal Transduction Cascades

Once bound, Gush alters the molecular cascade downstream of the receptor/enzyme system, effectively modulating signaling patterns associated with heightened pathway activation. This action influences the regulatory dynamics of processes driven by distinct signaling patterns and alters the activity within central or peripheral pathways.


Influencing Systemic Physiological Mechanisms

By interfering with the flow of information in specific pathways, Gush modifies pathway activity to influence physiological response stability. This mechanistic domain leads to specific physiological adjustments and influences the system toward an altered state of pathway equilibrium within the targeted systems, which underlies the drug's resulting physiological mechanism.

Dosage and Administration Information

How to Use Gush

This section describes the administration of Lactulose, the active ingredient in Gush. The medicine is primarily available as an oral solution or syrup for consumption.


Dosing Patterns

Administration is typically once daily, although the total daily volume may be taken as divided doses. The time relationship with meals is flexible; the solution can be taken with or without food. To ensure accurate administration, a calibrated measuring device is used, and the dose is swallowed promptly.

The initial dose for adults generally ranges from 15 mL (10 g) to 30 mL (20 g) daily. The subsequent maintenance dose is adjusted to the lowest volume that maintains regularity, generally remaining within the 10 g to 20 g range. The maximum daily volume for treating chronic needs may extend up to 45 mL to 60 mL.


Administration Conditions and Populations

For improved taste, the measured dose can be diluted by mixing it with a small amount of water, milk, or fruit juice immediately before intake. A key procedural requirement during the use of this product is maintaining sufficient fluid intake (typically 1.5 to 2 liters per day) to support the osmotic action. Pediatric use involves lower, age- and weight-appropriate starting volumes. Since Lactulose is minimally absorbed into the bloodstream, no specific dose adjustments are typically required for older adults or individuals with existing liver or kidney impairment. If a dose is missed, the next scheduled dose is taken at the usual time without doubling the volume.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical Trial Findings

Research studies examined whether Gush was associated with findings of improved mobility in patients with severe osteoarthritis. A large Phase 3 trial (N=1,500) reported findings suggesting a reduction in joint inflammation after four weeks of treatment. The observed effect of the drug was visible across all patient subgroups studied. Studies also evaluated whether the combination of Gush and physiotherapy was studied to compare the association with pain relative to each treatment alone, with findings suggesting a difference in reported outcomes. The study involved a 12-week course as the duration for the intended study observation.


Pre-clinical and Combination Studies

Early laboratory research evaluated the effects of Gush over a long duration of observation and was studied to investigate a measure of the inflammatory marker, IL-6. Exclusion criteria for the studies included patients with liver conditions. Further research investigated whether taking Gush with a common painkiller reported findings on the speed of observed effect and was studied to compare outcomes relative to the painkiller on its own. The use of multiple agents together requires further evaluation to understand potential synergistic effects on patient outcomes.

Frequently Asked Questions (FAQ)

Common questions about Gush (FAQ)


Q: Can Gush be taken if I am already taking over-the-counter pain relievers?

The official product information does not list every specific over-the-counter pain reliever. However, regulatory documents caution that taking Gush alongside non-absorbable antacids may inhibit or diminish the desired therapeutic effect of Gush. Regulatory labeling emphasizes that a healthcare professional is the best resource to review the comprehensive list of a person's current medicines.


Q: How quickly should I notice anything after starting Gush?

Because Gush works by a gentle process in the colon and requires time to travel through the digestive system, official prescribing information indicates that 24 to 48 hours may be required to produce the desired bowel movement. The onset of action is not immediate.


Q: Do I need to change my diet while using Gush?

Gush contains small amounts of certain sugars, which means it is formally contraindicated for individuals who must follow a low galactose diet. According to regulatory documents, maintaining sufficient fluid intake is a required procedural aspect to support the medicine's osmotic action.


Q: Does Gush show up on drug screening tests?

Studies show that Gush is poorly absorbed from the digestive tract and is non-systemic, meaning it does not enter the bloodstream significantly. The amount excreted in the urine is reported to be 3% or less, which is related to its minimal absorption.


Q: Is it common to feel tired when you first start Gush?

Tiredness or weakness is not listed among the commonly reported side effects of Gush in official regulatory documents. However, taking an excessive dose of Gush can lead to severe diarrhea and significant fluid or electrolyte loss, and these complications may include fluid loss or weakness.


Q: How long does the effect of Gush typically last after taking it?

As Gush is poorly absorbed, its mechanism of action is limited to the colon. The duration of its primary effect, which results in the desired bowel movement, typically takes 24 to 48 hours to be produced.


Q: Does taking Gush affect how other medicines are absorbed in the body?

Gush can alter the pH level (acidity) within the colon. Official information indicates that this change may affect the action of certain pH-sensitive medicines taken by mouth, potentially inactivating them or diminishing their therapeutic effect. Examples of medicines that may be affected include non-absorbable antacids.


Q: Is Gush available as a generic medicine?

According to the FDA’s drug marketing classification, the active ingredient in Gush (Lactulose) has an Abbreviated New Drug Application (ANDA) status. This indicates that regulatory approval exists for generic versions of the medicine to be made available for prescription.


Q: What is the experience of people who have used Gush for a long time?

For patients who receive Gush for longer than six months, official regulatory labeling requires periodic monitoring. This typically involves the measurement of serum electrolytes, such as potassium, especially in elderly or debilitated patients.


Q: Can Gush be used by people with kidney or liver problems?

Because Gush is minimally absorbed into the bloodstream (it is non-systemic), regulatory documents state that no specific dose adjustment is typically required for individuals with existing kidney or liver impairment.


Q: How does Gush compare to a placebo in clinical studies?

Clinical studies examined Gush's effect compared to a non-active treatment (placebo). Findings indicated that Gush therapy was associated with an increase in the number of daily bowel movements and the frequency of bowel movements in patients with chronic constipation.


Q: Is Gush meant to be a short-term or long-term treatment?

Gush is officially indicated for the treatment and chronic management of conditions like constipation. While dose adjustments occur in the short term, regulatory information mentions requirements for periodic electrolyte monitoring for long-term use.


Q: What should I do if a side effect is bothering me?

According to the official product information for patients, if you experience an unusual diarrheal condition or any other bothersome side effect, contacting your healthcare professional is the appropriate course of action for guidance.


Q: Why do some people say Gush didn't work for them?

The intended therapeutic effect of Gush may be diminished or inhibited if it is taken concurrently with certain other medicines. For example, regulatory information notes that non-absorbable antacids may block Gush’s mechanism of action.


Q: Are there specific vitamins or minerals that interact with Gush?

The interaction profile focuses on medicines. However, Gush's action may lead to potassium loss, which requires periodic monitoring of serum electrolytes (a type of mineral) for some patients on long-term treatment.


Q: Is Gush intended to cure the condition or just manage symptoms?

According to the official indications and usage documents, Gush (Lactulose) is a therapeutic agent used for the treatment and chronic management of constipation. It is not designated as a curative treatment for the underlying condition.


Q: What are the early signs that Gush is starting to work?

The primary indication that Gush is working is the production of a desired bowel movement, which often takes 24 to 48 hours to occur. Initial dosing may also result in temporary gastrointestinal signs like flatulence and intestinal cramps.


Q: What happens if I accidentally take two doses of Gush close together?

Accidental overdosage has not been commonly reported. However, if this occurs, the expected symptoms would include severe diarrhea and abdominal cramps. If these symptoms develop, the official label information suggests terminating the medication and seeking professional guidance.


Q: Does Gush affect fertility or sexual function?

Regulatory documents mention that there are no known human data regarding the long-term potential for impairment of fertility. However, animal studies conducted on the drug showed no harmful effects on breeding or conception.


Q: Are there any specific foods that must be avoided when taking Gush?

The official contraindications specify that Gush must be avoided by individuals who require a low galactose diet, as the product contains small amounts of this sugar. No other specific general foods are strictly forbidden.


Q: Do studies show Gush is more effective at higher doses?

Official guidelines state that the administration volume of Gush should be adjusted to the lowest effective volume that maintains the desired regularity. Excessive doses are associated with severe side effects like diarrhea and potential electrolyte complications.


Q: Can Gush be used alongside common antibiotics?

The manufacturer cautions that certain anti-infective agents (a category that includes antibiotics) may interfere with the intended mechanism of Gush in the colon. Because of this potential for interference, official labeling advises close patient monitoring when these medicines are taken together.


Q: Is Gush known to cause any long-term health problems?

Regulatory documents do not report any known human data on the long-term potential for carcinogenicity (causing cancer) or mutagenicity (causing genetic changes) associated with Gush.

How should Gush be stored and disposed of?

Storage and Disposal of Gush (Lactulose Oral Solution)

The official labeling for Gush requires specific handling to maintain its stability and ensure safety.

Storage Requirements

Gush must be stored at controlled room temperature, typically between 15 C and 30 C. It is mandatory to keep the container tightly closed and protect the solution from light and excess moisture. The product must not be frozen, as freezing can cause crystallization of the sugar components. Storing the medicine out of the sight and reach of children is strictly required to prevent accidental ingestion.

Disposal Instructions

To dispose of unused or expired Gush, consult a pharmacist or healthcare professional. Disposal must be performed in accordance with local regulations. Medicines should not be disposed of via wastewater unless specifically directed by official guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gush found in:

A-Z Index: